Drugs / iodinated contrast dye
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT00004152 Background | Feb 1999 → Dec 2002 | cutaneous melanoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| — | NCT01082224 Background | Dec 2010 → Dec 2023 | liver cancer | American College of Radiology Imaging Network | Unknown | No outcome recorded |
| — | NCT00004936 Background | Apr 2000 → May 2001 | cervical cancer | American College of Radiology Imaging Network | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodinated contrast dye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004152 ↗ |
| Modality | Diagnostic / imaging agent | “Iodinated contrast dye is administered by IV injection and by mouth followed by CT imaging of the chest, abdomen, and pelvis within 2 weeks of PET imaging.” NCT00004152 ↗ |
| Route | Intravenous | “Iodinated contrast dye is administered by IV injection and by mouth followed by CT imaging of the chest, abdomen, and pelvis within 2 weeks of PET imaging.” NCT00004152 ↗ |
| Route | Oral | “Iodinated contrast dye is administered by IV injection and by mouth followed by CT imaging of the chest, abdomen, and pelvis within 2 weeks of PET imaging.” NCT00004152 ↗ |